MGNX
MACROGENICS INC
Key Financials
Operating Income
$-72841000
↑ 34.1%
Net Income
$-74620000
↓ 11.4%
Revenue
$149.5M
↓ 0.3%
Total Liabilities
$201.3M
↑ 38.2%
EPS (Diluted)
$-1.18
↓ 10.3%
Cash & Equivalents
$57.2M
↓ 68.7%
Shareholders' Equity
$55.6M
↓ 52.1%
Total Assets
$256.8M
↓ 1.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/8/2026 | View on SEC |
| DEFA14A | 4/8/2026 | View on SEC |
| DEF 14A | 4/8/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 8-K | 3/9/2026 | View on SEC |
| 10-K | 3/9/2026 | View on SEC |
| 8-K | 3/2/2026 | View on SEC |
| 8-K | 2/24/2026 | View on SEC |
| SCHEDULE 13G/A | 2/17/2026 | View on SEC |
| 4 | 2/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MGNX |
| Company Name | MACROGENICS INC |
| CIK | 1125345 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 301-251-5172 |